Latest News
First Patient Transplanted iPSC-Derived Corneal Endothelial Cell Substitute
30 March 2023 - - Japan-based regenerative medicine startup Cellusion Inc's research collaborator, Dr. Shigeto Shimmura, Professor of Fujita Health University and Keio University presented at the 22nd Japanese Society for Regenerative Medicine A...
Resilience Approved for USD 410m Financing from the Department of Defense
30 March 2023 - - US-based biomanufacturing company National Resilience, Inc has signed a finance agreement for USD 410m in long-term loan financing from the US Department of Defense, working with the US International Development Finance Corp, the co...
Quantum-Si to Participate in B. Riley Securities' Life Sciences Tools Conference - Proteomics Setting the Blueprint for Innovative Drug Creation, Virtual Conference
30 March 2023 - - US-based protein sequencing company Quantum-Si Inc. (NASDAQ: QSI) will be participating in B. Riley Securities' Life Sciences Tools Conference - Proteomics Setting the Blueprint for Innovative Drug Creation, Virtual Confer...
Maze Therapeutics Posts New Clinical Data Supporting MZE001 as a Potential Treatment for Pompe Disease
30 March 2023 - - US-based Maze Therapeutics, a company translating genetic insights into new precision medicines, has posted new data from an exploratory muscle biopsy cohort of its Phase 1 clinical trial of MZE001 in healthy volunteers to evaluate ...
Genialis raises USD13m in Series A financing to build clinical biomarkers that predict patient response
30 March 2023 - Genialis, a Slovenia-based computational precision medicine company involved in complex biology to find new ways to address disease, announced on Wednesday that it has raised more than USD13m in a Series A financing to transform the w...